Today's Spotlight
Immuneering (IMRX) Stock Skyrockets: Clinical Breakthrough Fuels Investor Optimism
Immuneering Corporation (NASDAQ: IMRX) is witnessing a notable surge of 43.46% in its stock value, currently standing at $2.76, propelled by a significant breakthrough in
